Who Will Control Access to New Alzheimer’s Treatments?
Very few of the more than 5 million Americans, or their caregivers, who live with Alzheimer’s have ever heard of the Institute for Clinical and Economic Review.
Securing Babies’ Access to Life-Saving Medicine
Bringing a newborn baby home from the hospital is a joy like no other. Bringing that same baby back to the hospital for treatment of a life-threatening virus would be a nightmare. Yet for tens of thousands parents, RSV makes that traumatic return trip a reality.
ICER Alzheimer’s Report
Who decides which medications are available to the 5 million Americans living with Alzheimer’s? Increasingly, questions of access are informed by the Institute for Clinical and Economic Review, or ICER. The health economics organization uses clinical trials data and available pricing information to consider whether a drug is worth its cost. Now, ICER is reviewing […]
Are Insurers Slighting Sjögren’s Patients?
When you have a disease nobody has heard of, it’s easy to feel alone. And when insurance companies make it harder for you to access treatment, it can become even more disheartening. I know these feelings all too well.
Why Medical Innovation is Slow to Reach Patients
It can take 17 years for medical breakthroughs to move from the lab to the clinic, where patients can finally benefit. Why the lag?
How Telehealth Changed My Mom’s Life
Watching a patient eat. Asking about family photos on the nearby coffee table. Observing the living space. These are all benefits of telemedicine that help doctors see their patients through a new lens.
Will Insurers Come Through for Respiratory Patients?
This could be a life-changing year for chronic respiratory patients.
For Some, Step Therapy Is a Matter of Death or Life
I had been experiencing chest pain for a while. It was robbing me of joy – and it was often embarrassing.
Insurers Block Pain-Blocking Devices for Migraine
For the 39 million Americans who experience migraine headaches, noninvasive devices offer a new option for stopping painful symptoms. Insurers, however, are giving the devices the cold shoulder.
Insurers Save Costs at Cost of Skin Patients
Everyone, it seemed, was willing to help patients access medication without delay when COVID-19 took hold last year.
